Jeffrey E. Russel

Array ( [id] => 5085825 [patent_doc_number] => 20070275876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Method to increase the bioavailability of cysteine' [patent_app_type] => utility [patent_app_number] => 11/805637 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31083 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275876.pdf [firstpage_image] =>[orig_patent_app_number] => 11805637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13816 [patent_doc_number] => 07803775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Protein kinase C peptides for use in withdrawal' [patent_app_type] => utility [patent_app_number] => 11/805436 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 51 [patent_no_of_words] => 12973 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803775.pdf [firstpage_image] =>[orig_patent_app_number] => 11805436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282901 [patent_doc_number] => 08217000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Method for elevating prolactin in mammals' [patent_app_type] => utility [patent_app_number] => 12/300595 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 25019 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12300595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933448 [patent_doc_number] => 20080004223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'DERMATOLOGICAL USES OF THE TRIPEPTIDE MELANOCYTE STIMULATING INHIBITORY FACTOR (MIF)' [patent_app_type] => utility [patent_app_number] => 11/747748 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3556 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004223.pdf [firstpage_image] =>[orig_patent_app_number] => 11747748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933449 [patent_doc_number] => 20080004224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'DERMATOLOGICAL USES OF TRI-, TETRA-, PENTA-, AND POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/747762 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18843 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004224.pdf [firstpage_image] =>[orig_patent_app_number] => 11747762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639706 [patent_doc_number] => 20100036093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'CHOLESTEROLAMINE-INTRODUCED POLY-GAMMA-GLUTAMIC ACID DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/300001 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9845 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036093.pdf [firstpage_image] =>[orig_patent_app_number] => 12300001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421775 [patent_doc_number] => 08278264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Compositions and methods for enhancing drug delivery across and into ocular tissues' [patent_app_type] => utility [patent_app_number] => 11/800358 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 47 [patent_no_of_words] => 27609 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11800358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131567 [patent_doc_number] => 20070207964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Combined use of a GLP-1 compound and another drug for treating dyslipidemia' [patent_app_type] => utility [patent_app_number] => 11/799798 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6331 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207964.pdf [firstpage_image] =>[orig_patent_app_number] => 11799798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026538 [patent_doc_number] => 08536120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/298826 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 16769 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429076 [patent_doc_number] => 20090088386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'AMYLOID ß FIBRILLOGENESIS-INHIBITING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/298672 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6749 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088386.pdf [firstpage_image] =>[orig_patent_app_number] => 12298672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232480 [patent_doc_number] => 07597904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Metalloproteinase inhibitory agent' [patent_app_type] => utility [patent_app_number] => 11/739368 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8565 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/597/07597904.pdf [firstpage_image] =>[orig_patent_app_number] => 11739368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236233 [patent_doc_number] => 20100267621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Antimicrobial Compounds and Formulations' [patent_app_type] => utility [patent_app_number] => 11/738098 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20971 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267621.pdf [firstpage_image] =>[orig_patent_app_number] => 11738098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410661 [patent_doc_number] => 20090124560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Composition Containing Peptide as Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/226480 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8447 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124560.pdf [firstpage_image] =>[orig_patent_app_number] => 12226480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797849 [patent_doc_number] => 20080009435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them' [patent_app_type] => utility [patent_app_number] => 11/788866 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43562 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009435.pdf [firstpage_image] =>[orig_patent_app_number] => 11788866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866353 [patent_doc_number] => 20080145412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'METHOD OF PROMOTING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/735727 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145412.pdf [firstpage_image] =>[orig_patent_app_number] => 11735727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159349 [patent_doc_number] => 07674770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Anti-tumor drug, medicament, composition, and use thereof' [patent_app_type] => utility [patent_app_number] => 11/783654 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 21 [patent_no_of_words] => 9732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674770.pdf [firstpage_image] =>[orig_patent_app_number] => 11783654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069058 [patent_doc_number] => 20070190159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Polyamino acid-based insulin preparation' [patent_app_type] => utility [patent_app_number] => 11/786079 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4269 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190159.pdf [firstpage_image] =>[orig_patent_app_number] => 11786079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691488 [patent_doc_number] => 20070232545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Compositions and Methods for Treating Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/693820 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10922 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232545.pdf [firstpage_image] =>[orig_patent_app_number] => 11693820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528497 [patent_doc_number] => 20100015136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CAMPTOTHECIN-PEPTIDE CONJUGATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/295508 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22492 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015136.pdf [firstpage_image] =>[orig_patent_app_number] => 12295508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278053 [patent_doc_number] => 20090130185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Anti-Microbial Compositions Comprising a Cationic Peptide and a Glycylglycine Endopeptidase' [patent_app_type] => utility [patent_app_number] => 12/225441 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4535 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130185.pdf [firstpage_image] =>[orig_patent_app_number] => 12225441 [rel_patent_id] =>[rel_patent_doc_number] =>)